Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference38 articles.
1. Steroid receptors and other prognostic factors in primary breast cancer;Clark;Semin Oncol,1988
2. The origins of estrogen receptor α-positive and estrogen receptor α-negative human breast cancer;Allred;Breast Cancer Res,2004
3. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer;Slamon;Science,1989
4. Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance;Schiff;Clin Cancer Res,2004
5. Tamoxifen in the treatment of breast cancer;Osborne;N Engl J Med,1998
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells;International Journal of Molecular Sciences;2024-03-09
2. Breast tumors escape endocrine therapy by ER-independent mechanisms triggered by the coordinated activities of HER2/HER3 and deacetylated FOXA1;2020-09-23
3. Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer;Cancers;2019-05-28
4. Single molecule chromogenic in situ hybridization assay for RNA visualization in fixed cells and tissues;RNA;2019-05-07
5. Novel Therapies to Overcome HER2 Therapy Resistance in Breast Cancer;Resistance to Targeted Anti-Cancer Therapeutics;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3